Nutrigenomics: How Your Genes Affect Your Diet (Starting With Coffee)

CYP1A2 encodes the liver enzyme responsible for metabolizing roughly 95% of the caffeine you consume. A single SNP at rs762551 splits the population into two groups: fast metabolizers (AA genotype) and slow metabolizers (AC or CC genotype).

For fast metabolizers, caffeine clears the bloodstream quickly. Moderate coffee intake (2–3 cups/day) is associated with reduced risk of hypertension and improved athletic endurance. For slow metabolizers, the same dose lingers for hours. Research links more than two cups per day in slow metabolizers to elevated hypertension risk and — in some studies — higher risk of non-fatal heart attacks in adults under 50.

Same beverage. Same dose. Opposite health outcomes based on one SNP.

ACTN3 produces alpha-actinin-3, a protein found exclusively in fast-twitch muscle fibers. The R577X variant (rs1815739) determines whether you produce functional alpha-actinin-3 (RR or RX genotype) or don't produce it at all (XX genotype).

RR/RX carriers have a structural advantage for explosive, power-based activities — sprinting, jumping, weightlifting. XX carriers tend to excel at endurance activities — distance running, cycling, swimming. About 18% of the global population is XX (no alpha-actinin-3), and this variant is notably rare among elite sprinters but common among elite endurance athletes.

This doesn't mean your ACTN3 genotype determines your sport. It means your training program could be more effective if it accounts for your muscle fiber composition.

Most mammals stop producing lactase (the enzyme that digests milk sugar) after weaning. Humans who continue producing it into adulthood carry a variant near the LCT gene — a trait called lactase persistence. In populations with a long history of dairy farming (Northern Europeans, some African and Middle Eastern groups), lactase persistence is common. In East Asian, Southeast Asian, and many Indigenous populations, it's rare.

If you're lactose intolerant but forcing dairy because "it's good for your bones," your genome may be telling you to get calcium elsewhere. If you're avoiding dairy because the internet said it's inflammatory but you're genetically lactase-persistent, you might be skipping a nutrient-dense food for no biological reason.

The ALDH2*2 variant is carried by roughly 36% of East Asian populations and produces a non-functional version of aldehyde dehydrogenase 2, the enzyme that clears acetaldehyde — a toxic byproduct of alcohol metabolism. The result is the "Asian flush" reaction: facial flushing, nausea, and rapid heartbeat after even small amounts of alcohol.

This is not merely an inconvenience. Acetaldehyde is a Group 1 carcinogen. ALDH2*2 carriers who drink regularly face dramatically elevated esophageal cancer risk — up to 6–10× higher than non-carriers who drink the same amount. If you flush when you drink, your genome is giving you a direct, visible warning about cancer risk. It is one of the clearest gene-environment signals in all of human genetics.

FTO was the first gene robustly associated with obesity in genome-wide association studies. The risk allele (A) at rs9939609 is associated with increased appetite, reduced satiety signaling, and on average 2–3 kg higher body weight compared to non-carriers. About 16% of the population carries two copies (AA), and ~50% carry at least one.

FTO doesn't make weight loss impossible — it makes it require more deliberate effort. Carriers who are aware of their genotype can prioritize satiety-focused eating strategies (higher protein, higher fiber) and meal timing rather than fighting their biology with willpower alone.

The MTHFR C677T variant reduces the enzyme's ability to convert folic acid into its active form (methylfolate) by about 30% for CT carriers and 70% for TT carriers. This matters most during pregnancy (folate prevents neural tube defects) and for anyone on medications affected by folate metabolism.

We covered MTHFR in depth in our MTHFR gene explainer — the short version is that the variant is real and functional, but the supplement industry has wildly overstated its implications. Most people with MTHFR variants do fine with dietary folate from leafy greens. Targeted methylfolate supplementation is appropriate for TT carriers with documented low folate status, not as a blanket wellness protocol.